In the B cells of the spleen, TGR5 enhances insulin sensitivity and energy consumption, and is closely associated with glucose homeostasis: the activation of TGR5 has been demonstrated to control hyperglycemia and hyperinsulinemia in both a diet-induced obesity mouse model and human studies [64,66,67]. Here, GPBAR1 is linked to obesity disorder.